Rep. Ross Introduces the Right to FDA-Approved Medicines Act to Stop States From Banning Prescriptions
This bill is currently sitting in the House Committee on Energy and Commerce. No action has been taken on the proposal since July 2025, which means it has been stalled for 11 months. The committee must review the bill before it can move forward, but most bills like this never receive a vote.
Scores run from -100 (strongly harmful) to +100 (strongly beneficial) for each group, combining impact, certainty, scope, and duration ratings of 1-5. How impact scoring works
Independent pharmacies and small healthcare practices would gain explicit legal protections to dispense and prescribe FDA-approved medicines without fear of state punishment. The bill also provides a legal defense for providers who are sued or penalized under state restrictions, and allows them to recover attorney's fees if they win in court.
“A health care provider may commence an action for relief on its own behalf, on behalf of the provider's staff, and on behalf of the provider's patients who are or may be adversely affected by an alleged violation of this Act.”
Referred to the House Committee on Energy and Commerce.
Introduced in House
The bill was officially filed and given a number. It now enters the legislative queue.
No votes or related bills recorded for this bill yet.
Document Type
Congressional Bill
Official Title
Right to FDA-Approved Medicines Act
Analysis generated by AI. Always verify with official sources.